Status:
UNKNOWN
Oblique Lateral Interbody Fusion Versus Minimally Invasive Transforaminal Lumbar Interbody Fusion
Lead Sponsor:
Tang-Du Hospital
Conditions:
Lumbar Spinal Stenosis
Eligibility:
All Genders
50-80 years
Brief Summary
The investigators will retrospectively study lumbar spinal stenosis patients who underwent OLIF or MIS-TLIF with percutaneous pedicle screw fixation between January 2016 and December 2019.The investig...
Eligibility Criteria
Inclusion
- LSS due to neurogenic claudication; Central stenosis or lateral stenosis who need surgery; Single-level, low-grade (Meyerding grade 1 or 2) isthmic spondylolisthesis or degenerative spondylolisthesis; and imaging findings consistent with the symptoms of LSS.
Exclusion
- trauma, active infection, malignant tumors, spinal deformity, previous lumbar fusion, multi-segment fusion, multi-level, high-grade (Meyerding grade 3 or 4) isthmic spondylolisthesis or degenerative spondylolisthesis.
Key Trial Info
Start Date :
February 28 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 29 2021
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04778943
Start Date
February 28 2021
End Date
March 29 2021
Last Update
March 3 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.